Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2016 - 2025)
Zimmer Biomet Holdings has reported Cash from Investing Activities over the past 17 years, most recently at -$322.0 million for Q4 2025.
- Quarterly results put Cash from Investing Activities at -$322.0 million for Q4 2025, down 10.58% from a year ago — trailing twelve months through Dec 2025 was -$2.0 billion (down 122.46% YoY), and the annual figure for FY2025 was -$2.0 billion, down 122.46%.
- Cash from Investing Activities for Q4 2025 was -$322.0 million at Zimmer Biomet Holdings, down from -$163.3 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for ZBH hit a ceiling of -$81.1 million in Q1 2022 and a floor of -$1.4 billion in Q2 2025.
- Median Cash from Investing Activities over the past 5 years was -$159.1 million (2024), compared with a mean of -$230.4 million.
- Biggest five-year swings in Cash from Investing Activities: soared 53.45% in 2021 and later crashed 460.49% in 2025.
- Zimmer Biomet Holdings' Cash from Investing Activities stood at -$124.0 million in 2021, then increased by 9.27% to -$112.5 million in 2022, then crashed by 96.27% to -$220.8 million in 2023, then crashed by 31.88% to -$291.2 million in 2024, then decreased by 10.58% to -$322.0 million in 2025.
- The last three reported values for Cash from Investing Activities were -$322.0 million (Q4 2025), -$163.3 million (Q3 2025), and -$1.4 billion (Q2 2025) per Business Quant data.